Compliance Rate
Compliance Rate
33.33%
Compliant submissions
1
Incompliant submissions
2
Total trials
3
My Organizations' Clinical Trials
Showing 500 of 788 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 05/02/23
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 02/28/03
End: 03/31/05
Due: 03/31/06
Phase: N/A
Priority: Normal
Start: 03/07/22
End: 06/16/23
Due: 06/16/24
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 05/15/23
End: 04/23/25
Due: 04/23/26
Phase: N/A
Priority: Normal
Start: 01/28/20
End: 09/13/24
Due: 09/13/25
Phase: N/A
Priority: Normal
Start: 01/13/22
End: 03/20/23
Due: 03/20/24
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 05/13/24
End: 01/03/28
Due: 01/03/29
Phase: N/A
Priority: Normal
Start: 07/02/24
End: 06/03/25
Due: 06/03/26
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 04/16/24
End: 06/22/25
Due: 06/22/26
Phase: N/A
Priority: Normal
Start: 09/30/19
End: 01/30/24
Due: 01/30/25
Phase: N/A
Priority: Normal
Start: 07/11/18
End: 07/11/18
Due: 07/11/19
Phase: N/A
Priority: Normal
Start: 06/30/14
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 12/12/19
End: 03/12/21
Due: 03/12/22
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 02/06/18
End: 09/21/18
Due: 09/21/19
Phase: N/A
Priority: Normal
Start: 01/25/23
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 01/11/17
End: 11/13/22
Due: 11/13/23
Phase: N/A
Priority: Normal
Start: 02/12/18
End: 06/28/19
Due: 06/28/20
A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 05/31/16
Due: 05/31/17